Efficacy of neoadjuvant chemoradiotherapy in resectable esophageal squamous cell carcinoma: A single institutional study

Acta Oncologica

Volumn 42, Issue 3, 2003, Pages 207-217

  Lee, Jae Lyun ^a   Kim, Sung Bae ^a   Jung, Hwoon Yong ^a   Park, Seung Il ^a   Kim, Dong Kwan ^a   Kim, Jong Hoon ^a   Song, Ho Young ^a   Kim, Woo Kun ^a   Lee, Jung Shin ^a   Min, Young Il ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CATHODE RAY TUBES; CELLS; SURGERY; TUMORS;

CHEMORADIOTHERAPY;

CHEMOTHERAPY;

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ESOPHAGITIS; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; VOMITING;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PROGNOSIS; SURVIVAL;

EID: 0037862923     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860310010736     Document Type: Article

References (42)

1. Albertsson M. Chemoradiotherapy of esophageal cancer. Acta Oncol 2002; 41: 118-23.
2. Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of oesophageal carcinoma. Br J Surg 1990; 77: 845-57.
3. Wobst A, Audisio RA, Colleoni M, Geraghty JG. Oesophageal cancer treatment: studies, strategies and facts. Ann Oncol 1998; 9: 951-62.
4. Geh JI. The use of chemoradiotherapy in oesophageal cancer. Eur J Cancer 2002; 38: 300-13.
5. Forastiere AA, Orringer MB, Perez-Tamayo C, Urba SG, Zahurak M. Preoperative chemoradiation followed by transhiatal esophagectomy for carcinoma of the esophagus: final report. J Clin Oncol 1993; 11: 1118-23.
6. Bates BA, Detterbeck FC, Bernard SA, Qaqish BF, Tepper JE. Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma. J Clin Oncol 1996; 14: 156-63.
7. Stahl M, Wilke H, Fink U, et al. Combined preoperative chemotherapy and radiotherapy in patients with locally advanced esophageal cancer. Interim analysis of a phase II trial. J Clin Oncol 1996; 14: 829-37.
8. Adelstein DJ, Rice TW, Becker M, et al. Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma. Cancer 1997; 80: 1011-20.
9. Stockeld D, Tennvall J, Wagenius G, et al. A Swedish study of chemoradiation in squamous cell carcinoma of the esophagus. Acta Oncol 2001; 40: 566-73.
10. Nygaard K, Hagen S, Hansen HS, et al. Preoperative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of peroperative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. J Surg 1992; 16: 1104-9.
11. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
12. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer 1994; 73: 1779-84.
13. Walsh TN, Noonan N, Hollywood D, et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335: 462-7.
14. Urba SG, Orringer MB, Turrisi A, et al. A randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal cancer. J Clin Oncol 2000; 19: 303-13.
15. Ancona E, Ruol A, Santi S, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long-term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91: 2165-74.
16. American Joint Committee on Cancer: AJCC cancer staging manual 5th ed. Philadelphia, PA: Lippincott-Raven; 1997. p. 65-9.
17. Tio TL, Cohen P, Coene PP, et al. Endosonography and computed tomography of esophageal carcinoma. Preoperative classification compared to the new 1987 TNM system. Gastroenterology 1989; 96: 1478-86.
18. Burmeister BH, Smithers BM, Fitzgerald L, et al. A randomized phase III trial of peroperative chemoradiation followed by surgery versus surgery alone for localized resectable cancer of the esophagus. Proc Am Soc Clin Oncol 2002; Abstr 518.
19. Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 2000; 18: 868-76.
20. Carey RW, Hilgenberg AD, Wilkins EW Jr, et al. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 1993; 11: 99-105.
21. Hoff SJ, Stewart JR, Sawyers JL, et al. Preliminary results with neoadjuvant therapy and resection for esophageal carcinoma. Ann Thorac Surg 1993; 56: 282-6.
22. Powell ME, Hoskin PJ, Saunders MI, Foy CJ, Dische S. Continuous hyperfractionated accelerated radiotherapy (CHART) in localized cancer of the esophagus. Int J Radiat Oncol Biol Phys 1997; 38: 133-6.
23. Jeremic B, Shibamoto Y, Acimovic L, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998; 40: 1061-6.
24. Wright CD, Wain JC, Lynch TJ, et al. Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study. J Thorac Cardiovasc Surg 1997; 114: 811-5.
25. Raoul JL, Le Prise E, Meunier B, Heresbach D, Campion JP, Launois B. Neoadjuvant chemotherapy and hyperfractionated radiotherapy with concurrent low-dose chemotherapy for squamous cell esophageal carcinoma. Int J Radiat Oncol Biol Phys 1998; 42: 29-34.
26. Naunheim KS, Petruska PJ, Roy TS, Schlueter JM, Kim H, Baue AE. Multimodality therapy for adenocarcinoma of the esophagus. Ann Thorac Surg 1995; 59: 1085-90.
27. Jones DR, Parker LA Jr, Detterbeck FC, Egan TM. Inadequacy of computed tomography in assessing patients with esophageal carcinoma after induction chemoradiotherapy. Cancer 1999; 85: 1026-32.
28. Mallery S, DeCamp M, Bueno R, et al. Pretreatment staging by endoscopic ultrasonography does not predict complete response to neoadjuvant chemoradiation in patients with esophageal carcinoma. Cancer 1999; 86: 764-9.
29. Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000; 66: 827-31.
30. Brucher BL, Weber W, Bauer M, et al. Neoadjuvant therapy of esophageal squamous cell carcifioma: response evaluation by positron emission tomography. Ann Surg 2001; 233: 300-9.
31. Reed CE. Surgical management of esophageal carcinoma. Oncologist 1999; 4: 95-105.
32. Ferguson MK, Reeder LB, Hoffman PC, Haraf DJ, Drinkard LC, Vokes EE. Intensive multimodality therapy for carcinoma of the esophagus and gastroesophageal junction. Ann Surg Oncol 1995; 2: 101-6.
33. Bidoli P, Bajetta E, Stani SC, et al. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Cancer 2002; 94: 352-61.
34. Hennequin C, Gayet B, Sauvanet A, et al. Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus. Int J Radiat Oncol Biol Phys 2001; 49: 657-64.
35. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991; 20: 29-36.
36. Herskovic A, Martz K, al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593-8.
37. Minsky BD, Pajak TF, Ginsberg RJ, et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol 2002; 20: 1167-74.
38. Bedenne L, Michel P, Bouche O, et al. Randomized phase III trial in locally advanced esophageal cancer: radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102). Proc Am Soc Clin Oncol 2002; Abstr 519.
39. Adelstein DJ, Rice TW, Rybicki LA, et al. Does paclitaxel improve the chemoradiotherapy of locoregionally advanced esophageal cancer? A nonrandomized comparison with fluorouracil-based therapy. J Clin Oncol 2000; 18: 2032-9.
40. Urba S, Orringer M, Lannettoni M, et al. A phase II trial of preoperative cisplatin, paclitaxel, and radiation therapy before trans-hiatal esophagectomy in patients with locoregional esophageal cancer. Proc Am Soc Clin Oncol 2000; Abstr 960.
41. de Lange SM, van Groeningen CJ, Kroep JR, et al. Neoadjuvant cisplatin-gemcitabine plus GM-CSF in locally advanced esophageal cancer (LAEC): a phase II study. Proc Am Soc Clin Oncol 2002; Abstr 2396.
42. Keresztes R, Port J, Ferrara CA, Altorki NK. Taxol and carboplatin, an effective preoperative regimen for carcinoma of the esophagus: results of a phase II trial. Proc Am Soc Clin Oncol 2002; Aabstr 636.